CN Patent

CN105111135A — 取代的尿素衍生物制备方法

Assigned to Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd · Expires 2015-12-02 · 10y expired

What this patent protects

本发明涉及1-(4-氟苄基)-3-(4-异丁氧基苄基)-1-(1-甲基哌啶-4-基)脲半酒石酸盐（酒石酸匹莫范色林）新的制备方法，一种治疗帕金森病精神症类药物化合物，具有以下式（I）的结构式：本发明还涉及该制备方法新的中间体。

USPTO Abstract

本发明涉及1-(4-氟苄基)-3-(4-异丁氧基苄基)-1-(1-甲基哌啶-4-基)脲半酒石酸盐（酒石酸匹莫范色林）新的制备方法，一种治疗帕金森病精神症类药物化合物，具有以下式（I）的结构式：本发明还涉及该制备方法新的中间体。

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: CN105111135A
Jurisdiction: CN
Classification: —
Expires: 2015-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Anhui Province Yi Xinming Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.